Life Drug Patent Portfolio

Life owns 1 orange book drug protected by 3 US patents Given below is the list of Life's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9308284 Formulations Of Fluorinated Stilbene Suitable For Pet Imaging 14 Jul, 2032
Active
US7807135 Stilbene derivatives and their use for binding and imaging amyloid plaques 18 Mar, 2029
Active
US7907135 Image display and image displaying method for gradation correction 18 Mar, 2029
Active


Given below is the list of recent legal activities going on the following drug patents of Life.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 26 Sep, 2023 US9308284
Payment of Maintenance Fee, 12th Year, Large Entity 29 Apr, 2022 US7907135
Payment of Maintenance Fee, 12th Year, Large Entity 05 Apr, 2022 US7807135 (Litigated)
Payment of Maintenance Fee, 4th Year, Large Entity 08 Oct, 2019 US9308284
Payment of Maintenance Fee, 8th Year, Large Entity 12 Sep, 2018 US7907135
Payment of Maintenance Fee, 8th Year, Large Entity 05 Apr, 2018 US7807135 (Litigated)
Patent Issue Date Used in PTA Calculation 12 Apr, 2016 US9308284
Recordation of Patent Grant Mailed 12 Apr, 2016 US9308284
Email Notification 24 Mar, 2016 US9308284
Issue Notification Mailed 23 Mar, 2016 US9308284
Application Is Considered Ready for Issue 02 Mar, 2016 US9308284
Dispatch to FDC 02 Mar, 2016 US9308284
Issue Fee Payment Verified 26 Feb, 2016 US9308284
Issue Fee Payment Received 26 Feb, 2016 US9308284
Electronic Review 11 Dec, 2015 US9308284


Life's Family Patents

Life drugs have patent protection in a total of 26 countries. It's US patent count contributes only to 20.0% of its total global patent coverage. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Life Drug List

Given below is the complete list of Life's drugs and the patents protecting them.


1. Neuraceq

Neuraceq is protected by 3 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9308284 Formulations Of Fluorinated Stilbene Suitable For Pet Imaging 14 Jul, 2032
(6 years from now)
Active
US7807135 Stilbene derivatives and their use for binding and imaging amyloid plaques 18 Mar, 2029
(3 years from now)
Active
US7907135 Image display and image displaying method for gradation correction 18 Mar, 2029
(3 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Neuraceq's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List